Institutional Ownership
Calidi Biotherapeutics Inc
CUSIP 320703408COMCLDIQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
14.5%
Max % of class reported
Institutional Holders
26
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Mar 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 9, 2026 | Gavrilov Ognian Anguelov | 13D | 9.8% | — | SEC |
| 2 | Feb 10, 2026 | Lincoln Alternative Strategies LLC | 13G/A | — | — | SEC |
| 3 | Feb 4, 2026 | Gavrilov Ognian Anguelov | 13G | 7.8% | 560.0K | SEC |
| 4 | Aug 27, 2025 | Lincoln Alternative Strategies LLC | 13G | 14.5% | 730.0K | SEC |
| 5 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 117.4K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 879.0K | $209.9K |
| 2 | Sabby Management, LLC | 434.9K | $103.9K |
| 3 | Warberg Asset Management LLC | 250.0K | $59.5K |
| 4 | Hightower Advisors, LLC | 83.5K | $19.9K |
| 5 | Geode Capital Management, LLC | 63.0K | $15.0K |
| 6 | Rs Crum Inc. | 40.3K | $9.6K |
| 7 | Arax Advisory Partners | 37.3K | $8.9K |
| 8 | Jane Street Group, LLC | 34.8K | $8.3K |
| 9 | Belpointe Asset Management LLC | 19.9K | $4.8K |
| 10 | Northern Trust Corp | 17.8K | $4.2K |